AtriCure Inc

ATRC

Company Profile

  • Business description

    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

  • Contact

    7555 Innovation Way
    MasonOH45040
    USA

    T: +1 513 755-4100

    E: [email protected]

    https://www.atricure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    1,350

Stocks News & Analysis

stocks

ASX iron ore player downgraded ahead of earnings

Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks

Global tensions drive profitability for ASX energy provider

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,405.4059.700.64%
CAC 408,668.271.640.02%
DAX 4026,259.6757.320.22%
Dow JONES (US)54,601.58515.700.95%
FTSE 10010,911.9732.590.30%
HKSE25,915.8262.900.24%
NASDAQ26,723.03138.040.52%
Nikkei 22566,300.442,342.913.66%
NZX 50 Index13,997.1893.720.67%
S&P 5007,789.1652.640.68%
S&P/ASX 2009,227.8051.300.56%
SSE Composite Index3,878.4356.151.47%

Market Movers